• 1347 Citations
  • 21 h-Index
1980 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Z. Kahán is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Breast Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Hormones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1980 2019

Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy

Biro, E., Kahán, Z., Kalman, J., Rusz, O., Pákáski, M., Irinyi, T., Kelemen, G., Dudás, R., Drotos, G. & Hamvai, C., Jul 1 2019, In : In vivo (Athens, Greece). 33, 4, p. 1381-1392 12 p.

Research output: Contribution to journalArticle

Open Access
Aromatase Inhibitors
Gonadotropin-Releasing Hormone
Quality of Life

Decision curve analysis apropos of choice of preferable treatment positioning during breast irradiation

Rárosi, F., Boda, K., Kahán, Z. & Varga, Z., Oct 29 2019, In : BMC Medical Informatics and Decision Making. 19, 1, 204.

Research output: Contribution to journalArticle

Open Access
Decision Support Techniques
Linear Models
Prone Position
Logistic Models

Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: Results of a randomized, double-blind phase III clinical study vs. Reference pegfilgrastim in patients with breast cancer receiving chemotherapy

Kahán, Z., Grecea, D., Smakal, M., Tjulandin, S., Bondarenko, I., Perjesi, L., Illes, A., Horvat-Karajz, K. & Aradi, I., Feb 6 2019, In : BMC Cancer. 19, 1, 122.

Research output: Contribution to journalArticle

Open Access
Biosimilar Pharmaceuticals
Breast Neoplasms
Drug Therapy